Biocon Biologics bribery case: CBI moves HC challenging lower court verdict

The Delhi High Court has issued notices to the parties concerned and will hear the case on July 2

cbi
Press Trust of India New Delhi
2 min read Last Updated : Jun 28 2022 | 7:55 PM IST

The CBI approached the Delhi High Court on Tuesday challenging a lower court order denying it the custody of those arrested in the CDSCO bribery scandal allegedly involving a senior executive of Biocon Biologics, officials said.

The Delhi High Court has issued notices to the parties concerned and will hear the case on July 2, they said.

The CBI could not question the accused arrested by it even after six days, officials said and expressed apprehension that the delay might impede the investigation.

A special court here had sent all the five accused, including a joint drug controller at the Central Drugs Standard Control Organisation (CDSCO), to judicial custody after they were arrested for alleged bribery of Rs four lakh to waive phase-3 clinical trial of 'Insulin Aspart' injection of Biocon Biologics to manage Type 1 and Type 2 diabetes.

The CBI request seeking their police remand for custodial interrogation was denied twice by the special court which sent them to judicial custody.

Sources said CBI officials were disappointed that the court rejected their application for custody twice as immediate questioning after arrest in a trap case is of extreme importance for the agency so the accused do not get a chance to develop an alibi in their defence.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :BioconCBI

First Published: Jun 28 2022 | 7:53 PM IST

Next Story